CLINICAL_TRIALS
trial_result
· 2011-03-11
Clinical Trial Update: Neramexane for Tinnitus [Phase 2]
Summary
This update notes the completion of a Phase 2 clinical trial evaluating neramexane for tinnitus. The study was sponsored by Merz Pharmaceuticals GmbH.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merz Pharmaceuticals GmbH | Conditions: Tinnitus | Phase 2 | Status: COMPLETED